The Sydney Morning Herald logo

NeuroScientific Biopharmaceuticals

Advertisement
Neuroscientific Bio Pharmaceuticals has begun transferring its stem cell technology, StemSmart, to Q-Gen’s laboratories in Queensland. The move is designed to increase the company’s manufacturing capacity ahead of clinical trials.

NeuroScientific readies stem cell supply boost for bowel disease trials

NeuroScientific Biopharmaceuticals has begun transferring the production of stem cells for its StemSmart therapy to Q-Gen in Brisbane, ahead of Crohn’s disease clinical trials.

  • Doug Bright

Latest

NeuroScientific Biopharmaceuticals’ stem cell therapy helped 80 per cent of a small group of patients retain their donor kidneys, which were in danger of being rejected.

NeuroScientific stem cell studies show kidney transplant promise

NeuroScientific Biopharmaceuticals’ stem cell therapy helped 80% of a small group of kidney patients keep donor organs. The results could support the therapy’s entry into the US$7.2B immunotherapy market.

  • James Pearson
NeuroScientific Biopharmaceuticals is transferring its patented tech to one of Australia’s most experienced stem cell manufacturers to scale up production.

NeuroScientific locks in deal to scale-up stem cell production

NeuroScientific Biopharmaceuticals is transferring its patented tech to one of Australia’s most experienced stem cell manufacturers to scale up production.

  • James Pearson
Melbourne-based Nathan Smith will bring his extensive commercial, operation and strategic experience in developing stem cell therapies to his new role as chief executive officer at biotech company NeuroScientific Biopharmaceuticals.

Strategic CEO hire to drive NeuroScientific stem cell therapy release

NeuroScientific Biopharmaceuticals has made a second heavy-hitting appointment, with Melbourne-based exec Nathan Smith bringing his stem cell therapy nous as CEO.

  • James Pearson
Neuroscientific Biopharmaceuticals has appointed respected paediatric haematologist and oncologist Dr Catherine Cole as its chief medical officer.

NeuroScientific appoints top doctor ahead of stem cell therapy rollout

NeuroScientific Biopharmaceuticals is banking on its new, well-credentialled Perth-based chief medical officer to help the company roll out its innovative stem cell therapy.

  • James Pearson
Haematology medical scientist Dr Marian Sturm, NeuroScientific’s incoming chief scientific officer, pioneered the development of MSCs in her former role as facility director of Royal Perth Hospital’s Cell and Tissue Therapies centre.

New dawn for NeuroScientific with stem cell acquisition

NeuroScientific Biopharmaceuticals has ventured into the stem cell therapy market with a $5.1 million purchase of unlisted Perth-based company Isopogen.

  • Matt Birney
Advertisement
This week’s Bulls N’ Bears ASX Runner of the Week is… Grand Gulf Energy.

ASX Runners: Grand Gulf, Meteoric, Aus Strategic Materials & NeuroScientific

This week’s Bulls N’ Bears ASX Runner of the Week is… Grand Gulf Energy after it acquired an option over a billion-barrel oil prospect off the coast of Namibia.

  • Andrew Todd